Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium

NCT04731155 is registered in ClinicalTrials.gov with Shanghai Tong Ren Hospital as lead sponsor.

NCT NCT04731155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium
Lead sponsor
Shanghai Tong Ren Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
April 12, 2021
Completion date
October 31, 2025
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

early pcsk9 inhibitor on ventricular remodling